Stuart Therapeutics Unveils Phase III Results for Novel Dry Eye Candidate
ST-100 missed its primary endpoint—but showed visible healing on the eye’s surface by Day 4. Stuart Therapeutics (Florida, United States)…
Alcon Secures FDA Approval for TRYPTYR (Acoltremon Ophthalmic Solution) 0.003% for Dry Eye Disease
TRYPTYR, the first TRPM8-targeting eye drop, improves tear production from Day 1 in dry eye patients. Alcon (Geneva, Switzerland) has…
latest posts
